WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004006902) COMBINATION OF AN ALLOSTERIC INHIBITOR OR MATRIX METALLOPROTEINASE-13 WITH A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 THAT IS NOT CELECOXIB OR VALDECOXIB
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/006902    International Application No.:    PCT/IB2003/003196
Publication Date: 22.01.2004 International Filing Date: 30.06.2003
Chapter 2 Demand Filed:    21.08.2003    
IPC:
A61K 31/135 (2006.01), A61K 31/34 (2006.01), A61K 31/445 (2006.01), A61K 31/78 (2006.01), A61K 45/06 (2006.01)
Applicants: WARNER-LAMBERT COMPANY LLC [US/US]; 201 Tabor Road, Morris Plains, NJ 07950 (US) (For All Designated States Except US).
MEISEL, Gerard, Michael [US/US]; (US) (For US Only).
CIOCIOLA, Arthur, Anthony [US/US]; (US) (For US Only)
Inventors: MEISEL, Gerard, Michael; (US).
CIOCIOLA, Arthur, Anthony; (US)
Agent: LUMB, J., Trevor; Pfizer Inc., 201 Tabor Road, Morris Plains, NJ 07950 (US)
Priority Data:
10/193,475 10.07.2002 US
10/196,053 15.07.2002 US
Title (EN) COMBINATION OF AN ALLOSTERIC INHIBITOR OR MATRIX METALLOPROTEINASE-13 WITH A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 THAT IS NOT CELECOXIB OR VALDECOXIB
(FR) COMBINAISON D'UN INHIBITEUR ALLOSTERIQUE OU METALLOPROTEINASE MATRICIELLE-13 A INHIBITEUR SELECTIF DE CYCLOOXYGENASE-2 AUTRE QUE CELECOXIB OU VADECOXIB
Abstract: front page image
(EN)The invention relates to compositions and methods for treating and/or preventing lower gastrointestinal (GI) disorders in mammalian patients, more particularly for alleviating and/or preventing the lower GI symptoms associated with such disorders.
(FR)La présente invention a trait à des compositions et des procédés destinés au traitement et/ou à la prévention de troubles gastro-intestinaux bas chez des patients mammaliens, plus particulièrement le soulagement et/ou la prévention de symptômes gastro-intestinaux bas liés à de tels troubles.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PH, PL, PT, RO, RU, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)